PLA2G2A在肾乳头状细胞癌中的表达及临床意义
Expression and clinical significance of PLA2G2A in kidney renal papillary cell carcinoma
Note：A. The expression levels of PLA2G2A in 26 different types of TCGA tumors. B. The expression levels of PLA2G2A in different types of tumors were analyzed by combining TCGA and GTEx databases. BLCA—bladder urothelial carcinoma; BRCA—breast invasive carcinoma; CESC—cervical squamous cell carcinoma and endocervical adenocarcinoma; CHOL—cholangio carcinoma; COAD—colon adenocarcinoma; COADREAD—colorectal adenocarcinoma; ESCA—esophageal carcinoma; GBM—glioblastoma multiforme; GBMLGG—glioma; HNSC—head and neck squamous cell carcinoma; KICH—kidney chromophobe; KIPAN—pan-kidney cohort; KIRC—kidney renal clear cell carcinoma; KIRP—kidney renal papillary cell carcinoma; LGG—brain lower grade glioma; LIHC—liver hepatocellular carcinoma; LUAD—lung adenocarcinoma; LUSC—lung squamous cell carcinoma; PAAD—pancreatic adenocarcinoma; PCPG—pheochromocytoma and paraganglioma; PRAD—prostate adenocarcinoma; READ—rectum adenocarcinoma; STAD—stomach adenocarcinoma; STES—stomach and esophageal carcinoma; THCA—thyroid carcinoma; UCEC—uterine corpus endometrial carcinoma; T—tumor; N—normal.
